Health Insurance – Reimbursement and Use of Specific Pharmacies and Dispensaries – Prohibitions
Impact
The legislation is designed to improve access for patients by enabling them to choose their preferred pharmacy or dispensary without being restricted by insurance requirements. By repealing certain powers of pharmacy benefits managers, the bill ensures that patients can obtain specialty drugs from pharmacies that meet necessary performance standards, even if these pharmacies were not designated by their insurer. This could lead to a more competitive pharmaceutical market and potentially better prices for patients.
Summary
House Bill 650 aims to modify existing regulations surrounding health insurance reimbursement practices related to specialty drugs. The bill specifies that insurers, nonprofit health service plans, and health maintenance organizations cannot require a subscriber to obtain a covered specialty drug from any specific pharmacy or dispensary, although they can recommend certain entities. This regulation is intended to enhance patient choice regarding where they procure their medications.
Contention
Notable points of contention around HB 650 may arise from pharmacy benefits managers and insurance companies who typically have preferred pharmacies within their networks. Supporters of the bill advocate for patient autonomy and equity in healthcare, while opponents might argue that such regulations can lead to increased costs or complications in managing pharmacy benefits. The balance between insurer control and patient choice presents significant discussion points within the legislative process surrounding this bill.
An act to amend Section 1368.5 of the Health and Safety Code, to amend Section 10125.1 of the Insurance Code, and to amend Sections 14132.968 and 14132.969 of the Welfare and Institutions Code, relating to healing arts.
Provides for fair pharmacy reimbursement from a pharmacy benefit manager, and also provides anti-discrimination prohibitions in regard to non-affiliated pharmacies or pharmacists.
Provides for fair pharmacy reimbursement from a pharmacy benefit manager, and also provides anti-discrimination prohibitions in regard to non-affiliated pharmacies or pharmacists.